Treatment with Fermented
Mistletoe (Viscum Album L.) Extract as Part of Long-Term Supportive Care in
Patients with Primary Non-Metastatic Colorectal CArcinoma
W.E. Friedel MD, H. Matthes MD,
P. Heusser MD, MME, P.R. Bock MD
A multicenter, epidemiological,
observational cohort study on 804 (429 Iscador and 375 control) evaluable
patients from 26 centers in Germany and
Switzerland showed that the Iscador
treatment was well tolerated and was beneficial in the long-term supportive care
of patients with primary non-metastatic colorectal
carcinoma.
Colorectal_SIO 2007.red.pdf
Note: this poster was
presented at the 2007 SIO Conference in S.F. by Dr. Peter Heusser, former Head
of the Lukas Klinik, Arlesheim,
Switzerland.
Please address your questions or
comments to:
Michele Sanz
Medical Division Manager
Weleda North
America
1 Closter
Rd
Palisades, NY
10964
Phone:
1.800.241.1030, ext. 5550
Direct: 1.845.510.5550
Cell: 1.845.480.2260
Fax: 1.845.365.8260 /
michele@weleda.com